P&C PRODUCTS · 66-41 · ITALY
For P&C PRODUCTS, import alert is 66-41; country is ITALY; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Neoprosone-Gel Forte | Neoprosone-Gel Forte; product code is 64 L - - 67 Clobetasol Propionate (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 10/01/2021; address is Largo Desio , Milan, Milan ITALY, verified against its source on 2026-10-01.
- Firm
- P&C PRODUCTS verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- ITALY verified
- Address
- Largo Desio , Milan, Milan ITALY verified
- Date published
- 10/01/2021 verified
- Product code
- 64 L - - 67 Clobetasol Propionate (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Neoprosone-Gel Forte | Neoprosone-Gel Forte each item verified
- FDA notes
- The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’. | The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’. each item verified
What the source says
P&C PRODUCTS Date Published : 10/01/2021 Largo Desio , Milan, Milan ITALY
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
64 L - - 67 Clobetasol Propionate (Glucocorticoid) Date Published: 10/01/2021 Desc: Neoprosone-Gel Forte Notes: The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 10/01/2021 Desc: Neoprosone-Gel Forte Notes: The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’.
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.